Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes

Cited by (215)

Items 101–200 of 215

1. The Role, Potential Benefits and Cost-effectiveness of Digital Tools for Diabetes Management
   Anders L. Carlson, Sameer Badlani, Viral N. Shah · 2025 · Clinical Therapeutics
2. Differences in positive expectancy of hybrid closed loop (HCL) insulin delivery systems do not explain racial differences in HCL use
   J Grundman, AMANDA G. PERKINS, Maureen C. Monaghan, Seema Meighan, Randi M. Streisand, Brynn E. Marks · 2023 · Journal of Clinical & Translational Endocrinology
3. Review of Patient Perspectives and Psychosocial Experiences With Automated Insulin Delivery in Pregnancy With Type 1 Diabetes
   CHRISTINE P. FIELD, Kartik Kailas Venkatesh, Elizabeth Buschur · 2025 · Journal of Diabetes Science and Technology
4. Type 1 Diabetes Management in the Female Population: Evaluation of the Impact of Sex on Glycemic Control and the Perceived Performance of Diabetes Technology Across the Menstrual Cycle
   Chiara Fabris, Dillon Flanagan, Chloe Bennett, Annanda Fernandes Moura B. Batista, Mary Clancy Oliveri, Linda A Gonder-Frederick · 2025 · Diabetes Spectrum
5. Effectiveness of AI-driven interventions in glycemic control: A systematic review and meta-analysis of randomized controlled trials
   Khadija Elmotia, Oumaima Abouyaala, Soukaina Bougrine, Moulay Laarbi Ouahidi · 2025 · Primary care diabetes
6. Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
   Peter G. Jacobs, Carol Joan Levy, Sue A. Brown, Michael Charles Riddell, Ali Çınar, Charlotte K. Boughton, Marc D. Breton, Eyal Dassau, Gregory P. Forlenza, Robert J. Henderson et al. · 2025 · Diabetes Technology & Therapeutics
7. Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems
   Richard M. Bergenstal, Adam Heller, Marc D. Breton, Robert Alan Vigersky, Susan A. Brown, Gregory P. Forlenza, Jennifer L. Sherr, Roman Hovorka, Steven J. Russell, Edward R. Damiano et al. · 2025 · Diabetes Technology & Therapeutics
8. AI in optimized cancer treatment: laying the groundwork for interdisciplinary progress
   Gabriel Kalweit, Evelyn Ullrich, Joschka Boedecker, Roland Mertelsmann, Gabriel Kalweit · 2025 · Oxford Open Immunology
9. Metabolic Models, in Silico Trials, and Algorithms
   Ali Çınar, Ananda Basu, B. Wayne Bequette, Marc D. Breton, Bruce A. Buckingham, Eda Cengiz, Claudio Cobelli, Eyal Dassau, Francis J. Doyle, Chiara Fabris et al. · 2025 · Journal of Diabetes Science and Technology
10. Closed-Loop, Artificial Intelligence-Based Decision Support Systems, and Data Science
    Revital Nimri, Moshe Phillip, Mark Allen Clements, Boris P. Kovatchev · 2025 · Diabetes Technology & Therapeutics
11. Biases in Glucose Metrics Are Directly Related to Low Coverage of Continuous Glucose Monitoring: Insights from Diverse Populations
    Simon Lebech Cichosz, Niels Væver Hartvig, Thomas Kronborg, Stine Hangaard, Peter Vestergaard, Morten Hasselstrøm Jensen · 2025 · Diabetes Technology & Therapeutics
12. Real-World Clinical Impact of Using Personal Glucose Targets in a Hybrid Closed-Loop System Differs According to Age
    Julia Ware, Simon Bergford, Peter M. Calhoun, Judy Sibayan, Malgorzata E. Wilinska, Yue Ruan, Roman Hovorka · 2025 · Diabetes Technology & Therapeutics
13. Automated Insulin Delivery for Minoritized and Nonminoritized Populations With Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Puguh Oktavian, Citrawati Dyah Kencono Wungu, Sony Wibisono, Indah Mohd Amin · 2025 · Endocrine Practice
14. From narratives to numbers and back: Assessing the psychosocial aspects of diabetes in the era of high technology with emerging qualitative and quantitative methodologies
    Dominic Ehrmann, Eloise Litterbach, Sonya S. Deschênes, Rita Forde, Norbert Hermanns, Maaike Horsselenberg, Mandy Jansen, Amy M. McInerney, Eimear C. Morrissey, ANDREAS J. SCHMITT et al. · 2026 · Diabetic Medicine
15. Overview of Currently Available Insulin Delivery Systems
    Hayley Fried · 2024 · Contemporary Endocrinology
16. Meals No Longer Need to be Math Problems: Shifting from Precise Carbohydrate Counting to a Continuum of Carbohydrate Awareness as Automated Insulin Delivery Advances
    Becky Sulik, Kelly Postiglione Cook, Janice MacLeod · 2025 · Diabetes Technology and Obesity Medicine
17. Update information on type 1 diabetes in children/adolescents and adults
    Junnosuke Miura, Yasuko Uchigata · 2023 · Journal of Diabetes Investigation
18. Interest in hybrid closed loop is high across the socioeconomic spectrum despite current inequalities in provision in a large UK diabetes centre
    Anna R. Dover, Stuart A. Ritchie, Rohana J. Wright, Emily M. McMurray, Mark W. J. Strachan, Roland H. Stimson, Shareen Forbes, Fraser W. Gibb · 2023 · Diabetic Medicine
19. Early Detection of Elevated Ketone Bodies in Type 1 Diabetes Using Insulin and Glucose Dynamics Across Age Groups: Model Development Study
    Simon Lebech Cichosz, Clara Bender · 2025 · JMIR Diabetes
20. Diabetes Without Math as Automation Advances: A Shifting Clinical Paradigm
    Pablo A. Mora, Kelly Postiglione Cook, Janice MacLeod · 2025 · Diabetes Technology and Obesity Medicine
21. EndoCompass project: research roadmap for diabetes, obesity, and metabolism
    Chantal Mathieu, Manuela Meireles, Uberto Pagotto, Martin Wabitsch, Indraneel Banerjee, Alberto Bartolomé, Tadej Battelino, Julia Beck, Francesco Chiarelli, Diva D. De León et al. · 2025 · European Journal of Endocrinology
22. Real-World HbA1c Following Initiation of the Omnipod 5 Automated Insulin Delivery System
    Carol Joan Levy, D Carlow, Dan Swift, Rana Rittgers-Simonds, Noelle N. Gronroos, Valery Walker, Erin K. Buysman, Gregory P. Forlenza · 2025 · Diabetes Technology & Therapeutics
23. Revolutionizing Diabetes Care: From Tech to Therapeutics
    Halis Kaan Aktürk, LAUREN A. WATERMAN, Erin C. Cobry · 2025 · Diabetes Metabolic Syndrome and Obesity
24. Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial
    Carolyne Schumacher, Michael A. Tsoukas, Laurent Legault, Melissa‐Rosina Pasqua, Gabrielle Kemp, Elisa Cohen, Richard Jones, Eyal Dassau, Ahmad Haidar · 2026 · Diabetes Technology & Therapeutics
25. A critical view of the revolution of precision medicine: genetics, epigenetics, sex, and gender
    Marek Glezerman, Aaron J. Ciechanover, Marianne J. Legato · 2023 · Elsevier eBooks
26. Clinical Practice Update: Inpatient Insulin Pump and Integrated Insulin Delivery Systems
    Son Nguyen, Georgia M. Davis, Madhuri Mukhopadhyay Vasudevan · 2023 · Contemporary Endocrinology
27. Insulin’s Legacy: A Century of Breakthroughs and Innovation
    Somar A. Hadid, Emily Zhang, William H. Frishman, Erika F. Brutsaert · 2024 · Cardiology in Review
28. Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management
    Gregory P. Forlenza, Ideen Tabatabai, Dana Michelle Lewis · 2024 · Diabetes Technology & Therapeutics
29. Emerging therapies targeting cardiovascular risk factors to prevent or delay the onset of heart failure
    Olisaemeka Zikora Akunne, Ogochukwu Emilia Anulugwo · 2024 · American Journal of Pharmacotherapy and Pharmaceutical Sciences
30. Cardiac autonomic neuropathy: impact on severe hypoglycemic unawareness and orthostatic hypotension in diabetic dysautonomia, a case series and review
    Chao Wu, Rakesh Reddy Devireddy, Andrew Zazaian, Sujata Kambhatla, Opada Alzohaili, Chadi Saad · 2024 · Cardiovascular Endocrinology & Metabolism
31. Weight gain as a complication of intensification of glucose control with automated insulin delivery systems
    Julia Kelly, Devin Steenkamp, Elizabeth Brouillard, Howard A. Wolpert · 2025 · Diabetic Medicine
32. Navigating Automated Insulin Delivery for Type 1 Diabetes Management During Pregnancy
    Christina Scifres, Erin M. Cleary, Madilyn Sheerer, Marissa Bowdler, Viral N. Shah · 2025 · Journal of Diabetes Science and Technology
33. Evaluating ChatGPT for Disease Prediction: A Comparative Study on Heart Disease and Diabetes
    Ebtesam Ahmad Alomari · 2025 · BioMedInformatics
34. Early Stages of Automated Insulin Delivery
    Howard Zisser, Roman Hovorka, Ananda Basu, Tadej Battelino, Charlotte K. Boughton, Marc D. Breton, Bruce A. Buckingham, Sue A. Brown, Daniel R. Cherñavvsky, Eyal Dassau et al. · 2025 · Diabetes Technology & Therapeutics
35. AI as an Always-available Oncologist: A Vision for AI-optimized Cancer Therapy Based on Real-time Adaptive Dosing at the Patient Level
    Luis García‐Valiña, Gabriel Kalweit, Ignacio Mastroleo, Anusha Klett, Joschka Boedecker, Roland H. Mertelsmann, Gabriel Kalweit · 2024 · Journal of Science Humanities and Arts - JOSHA
36. Randomized Trial of a Bionic Pancreas in Type 1 Diabetes
    Yuki Murata, Morihito Takita, Masahiro Kami · 2023 · New England Journal of Medicine
37. Adult’s Lived Experience Using the Insulin-Only Bionic Pancreas
    Kimberly P. Garza, Kelsey R. Howard, Marissa A. Feldman, Jill A. Weissberg-Benchell · 2024 · Journal of Diabetes Science and Technology
38. Islet transplantation in Korea
    Joonyub Lee, Kun-Ho Yoon · 2024 · Journal of Diabetes Investigation
39. The ‘Designer’ Artificial Pancreas: How Does Current Technology Mimic Pancreatic Physiology?
    Lucie Ayliffe Daly · 2025 · Cureus
40. Artificial Pancreas: The First 20 Years
    Francis J. Doyle, Boris P. Kovatchev · 2025 · Journal of Diabetes Science and Technology
41. The type 1 diabetes mellitus treatment
    Artem Mikhailovich Morozov, Anastasia Tsvetkova, E. V. Penyaz', V. A. Sitnova, A. Yu. Smyslova · 2025 · Russian Journal of Preventive Medicine
42. Clinician, Youth, and Parent Perspectives on Diabetes Technology Education
    Brynn E. Marks, S. Spence Meighan, Dorene F. Balmer, Randi M. Streisand, Joseph I. Wolfsdorf, Andrea True Kelly, Victoria A. Miller · 2025 · The Science of Diabetes Self-Management and Care
43. Aligning AI Payment Policy With Desired Outcomes Rather Than Inputs May Require Customized Pathways
    S. Kottilil, Amol S. Navathe · 2026 · Health Affairs
44. Recent Advances in the Management of Type 1 Diabetes in Children
    Nancy L. Beck · 2026 · Advances in Pediatrics
45. Beyond Glycemic Control: Biographical Disruption and the Lived Experience of Youth with Type 1 Diabetes
    Ariela Denise Orbea Cevallos, Alejandra Aguirre Benitez, Mayra Elizabeth Castillo Gonzáles, Jaime David Acosta-España · 2026 · Current Diabetes Reviews
46. Artificial intelligence in cardio-kidney-metabolic care: Transforming integrated disease management through data-informed innovation
    Clipper F. Young, Janice MacLeod · 2026 · International Journal of Obesity
47. Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes
    Georgia M. Davis, Gregory P. Forlenza, Bernhard Gehr, John Stuart Pemberton, Alfred Penfornis, Duy Do, Lauren M. Huyett, Trang T. Ly · 2026 · Diabetes Research and Clinical Practice
48. A bibliometric analysis of global trends in AI-driven digital health technologies for diabetes management
    Jingwen Song, Wenli Tao, Di Zhou, 李轩宾, Sijing Peng, Chunyan Li, Juan Yuan · 2026 · Medicine
49. Continuous Glucose Monitoring Metrics and Risks of Severe Hypoglycemia and Diabetic Ketoacidosis in Type 1 Diabetes: A Pooled Analysis
    Jiahuan Helen He, Natalie Rula Daya, Scott L. Zeger, Justin Basile Echouffo-Tcheugui, Michael Fang, Elizabeth Selvin · 2026 · Diabetes Care
50. Automated insulin delivery systems: Myths, legends and management of the Holy Grail
    Alex Mesa, Ignacio Conget · 2023 · Endocrinología Diabetes y Nutrición (English ed )
51. Automatische Insulindosierung (AID) bei Kindern und Jugendlichen mit Typ-1-Diabetes
    Martin Tauschmann · 2024 · Die Diabetologie
52. Enhanced Metabolic Control in a Pediatric Population with Type 1 Diabetes Mellitus Using Hybrid Closed-Loop and Predictive Low-Glucose Suspend Insulin Pump Treatments
    Irina Bojoga, Sorin Ioacără, Elisabeta Andreea Malinici, Victor Chiper, Olivia Georgescu, Anca Mirela Sîrbu, Simona Vasilica Fica · 2024 · Pediatric Reports
53. Early Stages of Automated Insulin Delivery
    Howard Zisser, Roman Hovorka, Ananda Basu, Tadej Battelino, Charlotte K. Boughton, Marc D. Breton, Bruce A. Buckingham, Sue A. Brown, Daniel R. Cherñavvsky, Eyal Dassau et al. · 2025 · Journal of Diabetes Science and Technology
54. Dosing Algorithms for Insulin Pumps
    Ali Çınar · 2025 · Diabetes Spectrum
55. UpToDate®
    2023 · The Nurse Practitioner
56. Seeking Simpler Solutions with Diabetes Technology
    Jennifer L. Sherr · 2022 · New England Journal of Medicine
57. New Contributions Towards Meal and Exercise Announcement-Free Artificial Pancreas Systems
    Iván Sala-Mira · 2023 · RiuNet (Universitat Politècnica de València)
58. Optimizing Glycemic Control in Type 1 Diabetic Patients using a Deep Learning-Based Artificial Pancreas with a Secure Glucagon and Insulin Delivery System
    Rohan Singh, Raj Raghavendra Rao · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
59. Continuous and Intermittent Glucose Monitoring in 2024
    Klemen Dovč, Bruce W. Bode, Tadej Battelino · 2025 · Diabetes Technology & Therapeutics
60. Artificial Pancreas: The First 20 Years*
    Francis J. Doyle, Boris P. Kovatchev · 2025 · Diabetes Technology & Therapeutics
61. ‘Bionic pancreas’ tames diabetes blood-sugar spikes
    2022 · Nature
62. Transplantationsmöglichkeiten für Patienten mit Diabetes und fortgeschrittener Niereninsuffizienz
    Christos Chatzikyrkou · 2023 · Die Diabetologie
63. Bionisches Pankreas verbessert Blutzuckereinstellung bei Typ-1-Diabetes
    Maria Weiß · 2023 · Diabetologie und Stoffwechsel
64. Kunstig bukspyttkjertel gir bedre diabeteskontroll
    Torbjørn Øygard Skodvin · 2022 · Tidsskrift for Den norske legeforening
65. Utility and Safety of Backup Insulin Regimens Generated by the Bionic Pancreas: A Randomized Study
    Nelly Mauras, Edward R. Damiano, Firas H. El-Khatib, Martin Chase Marak, Peter M. Calhoun, Katrina J. Ruedy, COURTNEY A. BALLIRO, Zoey Li, Roy W. Beck, Steven J. Russell · 2023 · Diabetes Technology & Therapeutics
66. Utility of Technology in the Treatment of Type 1 Diabetes: Current State of the Art and Precision Evidence
    Laura M. Jacobsen, Jennifer L. Sherr, Elizabeth G. Considine, Angela Chen, Sarah Peeling, Margo Hulsmans, Sara Charleer, Marzhan Urazbayeva, Mustafa Tosur, SELMA A. ALAMARIE et al. · 2023 · medRxiv
67. Bionic pancreas in children and adults with type 1 diabetes
    2023 · Journal of Paediatrics and Child Health
68. Populatiemanagement en nieuwe technologie in de moderne diabeteszorg: over het waarom en hoe van CloudCare
    Henk‐Jan Aanstoot, Sander Last, Nico Riegman, Dick Mul, Arjen Hoogendam, Maarten Akkerman, Henk J. Veeze · 2023 · Nederlands Tijdschrift voor Diabetologie
69. Typ-1-Diabetes – neue Aspekte in Therapie und Technologie 2023
    Thomas Schimmel, Thomas Ebert · 2023 · Die Diabetologie
70. How close are we to personalized pharmacotherapies and innovative technology for type 1 diabetes management?
    Kashif M. Munir, Stephen N. Davis · 2023 · Expert Opinion on Pharmacotherapy
71. Assessment of the Impact of Subcutaneous Catheter Change on Glucose Control in Patients with Type 1 Diabetes Treated by Insulin Pump in Open- and Closed-Loop Modes
    Jean‐Baptiste Julla, Pauline Jacquemier, Élisabeth Bonnemaison, Guy Fagherazzi, Hélène P. Hanaire, Pauline Schaepelynck, Mihaela Mihaileanu, Éric Renard, Yves Reznik, Jean‐Pierre Riveline · 2024 · Diabetes Technology & Therapeutics
72. Flash glucose monitoring in diabetes
    Annel Lameijer · 2024 · University of Groningen research database (University of Groningen / Centre for Information Technology)
73. Updates in the Management of Type 1 Diabetes
    Ritwika Mallik, Partha S. Kar · 2024 · Journal of the Association of Physicians of India
74. Current Pharmacological Treatments in Type 1 Diabetes and Patient Tolerability against New Generation Medicines
    Muzaffer Serdar Deniz · 2024 · IntechOpen eBooks
75. Getting the Patient Ready
    2024 · American Diabetes Association eBooks
76. Continuous Insulin Delivery Systems in the Management of Diabetes Mellitus
    Nicholas H E Mezitis, Spyros G.E. Mezitis · 2024 · Contemporary Endocrinology
77. Assessing the Accuracy of CGM Metrics: The Role of Missing Data and Imputation Strategies
    S. L. Cichosz, T. Kronborg, S. Hangaard, P. Vestergaard, M. H. Jensen · 2025 · medRxiv
78. Addressing Deskilling as Automated Insulin Delivery Advances: What Is the Backup Plan?
    Laura Russell, Kelly Postiglione Cook, Janice MacLeod · 2025 · ADCES in Practice
79. Developing and Evaluating a Natural Language Processing Algorithm to Detect Insulin Pump and Continuous Glucose Monitor Use in Electronic Health Records of Patients with Type 1 Diabetes
    Estelle Marla Everett, Ryan Alyson-Yao Tiu, Bing Zhu, Jeffrey Feng, NICHOLAS J. JACKSON, Joyce Graham, Eli Ipp, Nestoras Nicolas Mathioudakis, Alex A. T. Bui, Tannaz Moin · 2025 · Diabetes Technology & Therapeutics
80. Technological innovations in the treatment of diabetes over the last decade
    T.A. Sonia, Chandra P. Sharma · 2025 · Elsevier eBooks
81. Nutrition therapy in the era of automated insulin delivery
    Meryem Khadija Talbo, Franziska K. Bishop, DARIA A. IGUDESMAN, Karen D. Corbin, Angelica Cristello Sarteau, Elizabeth J. Mayer‐Davis, David M. Maahs · 2025 · Frontiers in Endocrinology
82. Insulins, Technologies, and Telemedicine
    Elisa Cipponeri, Laura Vitale, Ilaria Milani, Rosario Caruso · 2025 · Springer eBooks
83. Pharmacologic Therapy for Type 2 Diabetes
    2025 · American Diabetes Association eBooks
84. Pharmacologic Therapy for Type 1 Diabetes
    2025 · American Diabetes Association eBooks
85. EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism
    Chantal Mathieu, Manuela Meireles, Uberto Pagotto, Martin Wabitsch, Indraneel Banerjee, Alberto Bartolomé, Tadej Battelino, Julia Beck, Francesco Chiarelli, Diva D. De León et al. · 2025 · Hormone Research in Paediatrics
86. Additional file 1 of Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials
    Godoi, Amanda, Reis Marques, Isabela, Padrão, Eduardo M. H., Mahesh, Ashwin, Hespanhol, Larissa C., Riceto Loyola Júnior, José Eduardo, Isabela A F de Souza, Vittoria Caporal S Moreira, Silva, Caroliny H., Isabele Ayumi Miyawaki et al. · 2024 · Figshare
87. Insulin pumps and artificial pancreas
    Konstantinos P. Markakis, Andriani Vazeou · 2025 · Elsevier eBooks
88. The Tech Revolution
    Jenna Brothers · 2026 · Physician Assistant Clinics
89. Clinical outcomes of adults with type 1 diabetes and comorbid depression and/or anxiety disorders using hybrid closed‐loop: A retrospective study from a multidisciplinary tertiary centre
    Jonathan Croos, Adam Kia Shooshtarian, Ben Stotesbury, Geraldine Gallen, Khalida Ismail, Miranda J. Rosenthal, Yee Seun Cheah, Marilia Calcia, Kaylee Lovie, Anusha Ahuja et al. · 2026 · Diabetes Obesity and Metabolism
90. 7.2 Diabetes Tipo I
    Carolina Morais Guimarães, Iáskara David Cangussú Lima, Tatiliana Geralda Bacelar Kashiwabara · 2026
91. Automated insulin delivery systems and improved glycaemic outcomes in type 1 diabetes: what comes next?
    Dessi P. Zaharieva · 2026 · The Lancet Diabetes & Endocrinology
92. Kidney and Cardiovascular Protection in Diabetes: Beyond Diabetes Typology
    Amy K. Mottl, Deirdre L. Sawinski, Petter Bjornstad · 2026 · American Journal of Kidney Diseases
93. Automated Insulin Delivery for Patients with Type 2 Diabetes: A Narrative Review
    Konstantinos Kitsios, Christina Trakatelli · 2026 · Current Diabetes Reviews
94. The Virtual Diabetes Control and Complications Trial #4: Relationship of HbA1c and Continuous Glucose Monitoring Metrics with Severe Hypoglycemic Events
    Anika Bilal, William B. Horton, Boris P. Kovatchev, Anna Casu, RE Pratley, Lauren Kanapka, Roy W. Beck · 2026 · Diabetes Technology & Therapeutics
95. Causal mediation pathways in continuous postprandial glucose monitoring for type 1 diabetes patients
    Spencer Hilligoss, Annie Qu · 2026 · npj Metabolic Health and Disease
96. Attitudes and Barriers Toward Automated Insulin Delivery Systems Among Health Care Providers in Germany: A Network Analysis From the dt-Report
    Dominic Ehrmann, Timm Roos, Jens Kröger, Hansjörg Mühlen, Winfried Keuthage, Andreas Lueg, Nikolaus Scheper, Lutz Heinemann, Derek Brandt, Norbert Hermanns et al. · 2026 · Journal of Diabetes Science and Technology
97. From Device Data to Trusted Decision Support: Building the Foundation for AI in Hospital Insulin Management
    Mandy M. Shao, Agatha F. Scheideman, Casey Rand, David Charles Klonoff, Juan Espinoza · 2026 · Diabetology
98. Clinical Approaches to Managing Glycemia with the iLet Dosing Decision Software
    Irl B. Hirsch, Diana M. Isaacs, Pablo Mora, Sean M. Oser, Viral N. Shah, Becky Sulik, Kristine M. Wohlfahrt, Kelly Postiglione Cook, Janice MacLeod, Steven J. Russell · 2026 · Diabetes Technology and Obesity Medicine
99. Retrospective Real-world Analysis of Insulin Pump and Continuous Glucose Monitoring Technology Utilization in a Large Canadian Type 1 Diabetes Clinic
    Karl Vantomme, Samin Dolatabadi, Bikrampal Sidhu, Wilma M. Hopman, Robyn L. Houlden · 2026 · Canadian Journal of Diabetes
100. Percent Time Below Range Is Strongly Associated with Clinically Important Level 2 Hypoglycemia Events in Individuals with Type 1 Diabetes
     Peter M. Calhoun, Richard Liggins, Zoey Li, Michael Charles Riddell, Richard M. Bergenstal, Gregg D. Simonson, Viral N. Shah, Susan H. Peers, Jennifer L. Sherr, Roy W. Beck · 2026 · Diabetes Technology & Therapeutics